Septerna (SEPN) Other Non-Current Liabilities (2023 - 2026)
Septerna's (SEPN) quarterly Other Non-Current Liabilities came in at $100000.0 in Q1 2026, up 270.37% year-on-year from $27000.0 in Q1 2025, and up 4900.0% quarter-over-quarter from $2000.0 in Q2 2025.
Septerna (SEPN) Other Non-Current Liabilities (2023 - 2026) Analysis & Trends
Septerna's Other Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $100000.0 for Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 270.37% year-over-year to $100000.0 in Q1 2026; TTM through Mar 2026 was $100000.0, a 270.37% increase from a year earlier, with the FY2024 full-year figure at $33000.0, down 93.96% from the prior year.
- Other Non-Current Liabilities climbed to $100000.0 in Q1 2026 per SEPN's latest filing, from $2000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $546000.0 in Q4 2023 and bottomed at $2000.0 in Q2 2025.
- The 4-year median for Other Non-Current Liabilities is $66500.0 (2024), against an average of $149833.3.
- Across the five-year window, Other Non-Current Liabilities sank 93.96% in 2024 and surged 270.37% in 2026, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $546000.0 in 2023, then sank by 93.96% to $33000.0 in 2024, then tumbled by 93.94% to $2000.0 in 2025, then surged by 4900.0% to $100000.0 in 2026.
- Per Business Quant, the three latest SEPN Other Non-Current Liabilities figures stand at $100000.0 (Q1 2026), $2000.0 (Q2 2025), and $27000.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Septerna | 1.50 Bn | 1.50 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Dec 31, 2024 | 33,000.00 |
| Sep 30, 2024 | 191,000.00 |
| Dec 31, 2023 | 546,000.00 |